Thermo Fisher Scientific to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024
Jefferies Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Raises Target Price to $670
Express News | Wells Fargo Initiates Coverage On Thermo Fisher Scientific With Overweight Rating, Announces Price Target of $670
Thermo Fisher Scientific Inc. (TMO): Among Morgan Stanley's Highest Conviction Stocks
Is the rebound fading? Goldman Sachs: Hedge funds are selling stocks at the fastest pace in more than two years.
In August, 'smart money' is selling global equities at the fastest pace since March 2022, with the most net selling in North America. Hedge funds are skeptical of the sustainability of the stock market rebound, and geopolitical concerns continue to be worrying. The 'fly' of the economic situation may soon hit the glass windshield.
RNAi Market and Technologies Industry Report 2024, With Company Profiles of Major Players Including Alnylam Pharmaceuticals, Novartis, Thermo Fisher Scientific and Revvity
... 
104656319 : hy
webguybob : so how do we use moo to identify potential high performance stocks in the broader sectors?
73279472 : ok
71768068 webguybob : simply russell2000
webguybob 71768068 : I recently shifted most of my large caps to ishares IWF, so I might be covered?
View more comments...